BRIEF published on 12/18/2024 at 07:35, 3 days 11 hours ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
BRIEF published on 12/18/2024 at 07:35, 3 days 11 hours ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
PRESS RELEASE published on 12/18/2024 at 07:30, 3 days 11 hours ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
PRESS RELEASE published on 12/18/2024 at 07:30, 3 days 11 hours ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
BRIEF published on 11/06/2024 at 07:35, 1 month 15 days ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
BRIEF published on 11/06/2024 at 07:35, 1 month 15 days ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
PRESS RELEASE published on 11/06/2024 at 07:30, 1 month 15 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
PRESS RELEASE published on 11/06/2024 at 07:30, 1 month 15 days ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 3 months 1 day ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 3 months 1 day ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 52 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 27 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 5 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 12 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 46 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/21/2024 at 12:17, 6 hours 39 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 39 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
